← Open Payments lookup

NORMA FLORES: Open Payments

NPI 1811371537 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,305 in 97 payments from 16 companies in 2025. Trend: 2023 $1,871 · 2024 $2,873 · 2025 $3,305

Food & beverage: $3,305
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.15$800
E.R. Squibb & Sons, L.L.C.21$487
AstraZeneca Pharmaceuticals LP9$339
SCPHARMACEUTICALS INC.6$304
PFIZER INC.11$214
Alnylam Pharmaceuticals Inc.7$186
Medtronic, Inc.1$182
Novo Nordisk Inc7$149
Bayer Healthcare Pharmaceuticals Inc.2$135
Boston Scientific Corporation2$118

Products named: JARDIANCE, FUROSCIX, ELIQUIS, AMVUTTRA, Kerendia, VYNDAQEL, LOKELMA, Wegovy.

Industry payments across MD — which companies pay providers there.